Company Overview and News

 
France’s Bollore can buy majority stake in logistics firm India Ports only in 2021

2017-10-19 thehindubusinessline
Bollore Africa Logistics SAS, a unit of Paris Stock Exchange-listed Bollore Group, will have to wait at least till 2021 to raise its stake in an Indian logistics company to comply with the terms of the contract the local firm’s subsidiary was awarded to run a container terminal at VO Chidambaranar Port Trust (VOCPT) in Tamil Nadu’s Tuticorin district.

 
Bidders turn ‘realistic’ in quoting revenue share in major port auctions

2016-01-31 livemint
Port auctions had earlier fetched revenue shares exceeding 50% but some of them failed to materialize as lenders found the projects un-bankable due to the steep revenue share

 
Penske Automotive (PAG) Buys 49% Stake in Nicole Group

2016-01-08 zacks
Penske Automotive Group, Inc. (PAG) announced that it has acquired a 49% equity ownership interest in the Nicole Group

 
Magna International (MGA) Cut to Sell: Should You Dump It?

2016-01-08 zacks
On Jan 8, 2015, Zacks Investment Research downgraded Magna International Inc. (MGA) to a Zacks Rank #4 (Sell).

 
AutoNation's (AN) Warning Hits Dealership Stocks Hard

2016-01-07 zacks
Shares of AutoNation, Inc. (AN) fell 10.54% on Jan 6, after the auto retailer announced that it expects a decline in gross profit for the fourth quarter of 2015

 
7 Incredible Value Stocks You Must Buy for 2016

2016-01-04 zacks
7 incredible value stocks that are most likely to bear fruits in the year ahead.

 
MarineMax Form DEF 14A

2015-12-24 sec.gov
Notice and Proxy Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant  x                             Filed by a Party other than the Registrant  ¨ Check the appropriate box:   ¨   Preliminary Proxy Statement ¨   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x   Definitive Proxy Statement ¨   Definitive Additiona

 
VANGUARD VALLEY FORGE FUNDS Form N-Q

2015-12-01 sec.gov
valleyforge_final.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT COMPANY   Investment Company Act file number:   811-58431   Name of Registrant:   Vanguard Valley Forge Funds   Address of Registrant: P.O. Box 2600 Valley Forge, PA 19482   Name and address of agent for service: Heidi Stam, Esquire P.

 
LAZARD FUNDS INC Form N-Q

2015-12-01 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM N-Q   QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANIES   Investment Company Act file number 811-06312   The Lazard Funds, Inc. (Exact name of Registrant as specified in charter)   30 Rockefeller Plaza New York, New York 10112 (Address of principal executive offices) (Zip code)   Nathan A.

 
VANGUARD INSTITUTIONAL INDEX FUNDS Form N-Q

2015-12-01 sec.gov
institutionalindex_final.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT COMPANY   Investment Company Act file number:    811-06093   Name of Registrant:   Vanguard Institutional Index Funds   Address of Registrant: P.O. Box 2600 Valley Forge, PA 19482   Name and address of agent for service: Heidi Stam, Esquire P.

 
FIRST INVESTORS LIFE SERIES FUNDS Form N-Q

2015-12-01 sec.gov
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 -------- FORM N-Q -------- QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY INVESTMENT COMPANY ACT FILE NUMBER 811-4325 FIRST INVESTORS LIFE SERIES FUNDS (Exact name of registrant as specified in charter) 40 Wall Street New York, NY 10005 (Address of principal executive offices) (Zip code) Joseph I.

 
VANGUARD INDEX FUNDS Form N-Q

2015-12-01 sec.gov
index_final.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT COMPANY   Investment Company Act file number:   811-02652   Name of Registrant:   Vanguard Index Funds   Address of Registrant: P.O. Box 2600 Valley Forge, PA 19482   Name and address of agent for service: Heidi Stam, Esquire P.

 
Wildermuth Endowment Strategy Fund Form EX-99.CERT

2015-12-01 sec.gov
CERTIFICATIONS   I, Daniel Wildermuth, certify that:   1. I have reviewed this report on Form N-Q of the Wildermuth Endowment Strategy Fund;   2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;   3.

 
Wildermuth Endowment Strategy Fund Form N-Q

2015-12-01 sec.gov
united states securities and exchange commission washington, d.c. 20549 form n-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act File Number 811-22888   Wildermuth Endowment Strategy Fund (Exact name of registrant as specified in charter)   11525 Park Woods Circle, Ste. 200, Alpharetta, GA 30005 (Address of principal executive offices) (Zip code)   Daniel Wildermuth, President 11525 Park Woods Circle, Ste.

 
KP Funds Form N-Q

2015-12-01 sec.gov
KP Funds     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM N-Q     QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-22838     The KP Funds (Exact name of registrant as specified in charter)     CT Corporation 101 Federal Street Boston, MA 02110 (Address of principal executive offices) (Zip code)     SEI Investments One Freedom Valley Drive Oaks, PA 19456 (Name and address of agent for se

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...